Annual D&A
$154.00 K
-$2.00 M-92.85%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual depreciation & amortization is $154.00 thousand, with the most recent change of -$2.00 million (-92.85%) on December 31, 2023.
- During the last 3 years, RSLS annual D&A has fallen by -$1.51 million (-90.76%).
- RSLS annual D&A is now -92.85% below its all-time high of $2.15 million, reached on December 31, 2022.
Performance
RSLS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$5000.00
-$1000.00-16.67%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly depreciation & amortization is $5000.00, with the most recent change of -$1000.00 (-16.67%) on September 30, 2024.
- Over the past year, RSLS quarterly D&A has dropped by -$45.00 thousand (-90.00%).
- RSLS quarterly D&A is now -99.10% below its all-time high of $555.00 thousand, reached on December 31, 2021.
Performance
RSLS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$24.00 K
-$45.00 K-65.22%
September 30, 2024
Summary
- As of February 7, 2025, RSLS TTM depreciation & amortization is $24.00 thousand, with the most recent change of -$45.00 thousand (-65.22%) on September 30, 2024.
- Over the past year, RSLS TTM D&A has dropped by -$638.00 thousand (-96.37%).
- RSLS TTM D&A is now -98.91% below its all-time high of $2.20 million, reached on June 30, 2022.
Performance
RSLS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
RSLS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -92.8% | -90.0% | -96.4% |
| 3 y3 years | -90.8% | -99.1% | -98.7% |
| 5 y5 years | -65.0% | -98.8% | -98.6% |
RSLS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.8% | at low | -99.1% | at low | -98.9% | at low |
| 5 y | 5-year | -92.8% | at low | -99.1% | at low | -98.9% | at low |
| alltime | all time | -92.8% | +60.8% | -99.1% | +116.0% | -98.9% | at low |
ReShape Lifesciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5000.00(-16.7%) | $24.00 K(-65.2%) |
| Jun 2024 | - | $6000.00(0.0%) | $69.00 K(-38.4%) |
| Mar 2024 | - | $6000.00(-14.3%) | $112.00 K(-27.3%) |
| Dec 2023 | $154.00 K(-92.8%) | $7000.00(-86.0%) | $154.00 K(-76.7%) |
| Sep 2023 | - | $50.00 K(+2.0%) | $662.00 K(-42.7%) |
| Jun 2023 | - | $49.00 K(+2.1%) | $1.16 M(-30.0%) |
| Mar 2023 | - | $48.00 K(-90.7%) | $1.65 M(-23.3%) |
| Dec 2022 | $2.15 M(+9.2%) | $515.00 K(-5.2%) | $2.15 M(-1.8%) |
| Sep 2022 | - | $543.00 K(-0.4%) | $2.19 M(-0.2%) |
| Jun 2022 | - | $545.00 K(-0.9%) | $2.20 M(+4.5%) |
| Mar 2022 | - | $550.00 K(-0.9%) | $2.10 M(+6.7%) |
| Dec 2021 | $1.97 M(+18.2%) | $555.00 K(+1.3%) | $1.97 M(+7.9%) |
| Sep 2021 | - | $548.00 K(+21.8%) | $1.83 M(+7.6%) |
| Jun 2021 | - | $450.00 K(+7.7%) | $1.70 M(+2.0%) |
| Mar 2021 | - | $418.00 K(+2.0%) | $1.66 M(-0.2%) |
| Dec 2020 | $1.67 M(-2.3%) | $410.00 K(-2.1%) | $1.67 M(-0.7%) |
| Sep 2020 | - | $419.00 K(+0.5%) | $1.68 M(-0.2%) |
| Jun 2020 | - | $417.00 K(-1.0%) | $1.68 M(-0.8%) |
| Mar 2020 | - | $421.00 K(0.0%) | $1.69 M(-0.7%) |
| Dec 2019 | $1.71 M(+287.7%) | $421.00 K(-0.2%) | $1.71 M(+20.7%) |
| Sep 2019 | - | $422.00 K(-1.9%) | $1.41 M(+29.6%) |
| Jun 2019 | - | $430.00 K(-0.7%) | $1.09 M(+42.6%) |
| Mar 2019 | - | $433.00 K(+235.7%) | $765.00 K(+73.9%) |
| Dec 2018 | $440.00 K(+64.1%) | $129.00 K(+30.3%) | $440.00 K(+4.6%) |
| Sep 2018 | - | $99.00 K(-4.8%) | $420.50 K(+2.2%) |
| Jun 2018 | - | $104.00 K(-3.7%) | $411.30 K(+18.5%) |
| Mar 2018 | - | $108.00 K(-1.4%) | $347.00 K(+29.4%) |
| Dec 2017 | $268.20 K(+92.1%) | $109.50 K(+21.9%) | $268.10 K(+42.0%) |
| Sep 2017 | - | $89.80 K(+126.2%) | $188.80 K(+45.6%) |
| Jun 2017 | - | $39.70 K(+36.4%) | $129.70 K(+0.3%) |
| Mar 2017 | - | $29.10 K(-3.6%) | $129.30 K(-7.4%) |
| Dec 2016 | $139.60 K(-26.3%) | $30.20 K(-1.6%) | $139.60 K(-8.5%) |
| Sep 2016 | - | $30.70 K(-21.9%) | $152.60 K(-10.7%) |
| Jun 2016 | - | $39.30 K(-0.3%) | $170.80 K(-5.2%) |
| Mar 2016 | - | $39.40 K(-8.8%) | $180.20 K(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $189.50 K(+0.3%) | $43.20 K(-11.7%) | $189.50 K(-2.0%) |
| Sep 2015 | - | $48.90 K(+0.4%) | $193.30 K(+1.0%) |
| Jun 2015 | - | $48.70 K(0.0%) | $191.30 K(+0.6%) |
| Mar 2015 | - | $48.70 K(+3.6%) | $190.10 K(+0.6%) |
| Dec 2014 | $188.90 K(+8.2%) | $47.00 K(+0.2%) | $188.90 K(-1.7%) |
| Sep 2014 | - | $46.90 K(-1.3%) | $192.10 K(+2.2%) |
| Jun 2014 | - | $47.50 K(0.0%) | $188.00 K(+4.4%) |
| Mar 2014 | - | $47.50 K(-5.4%) | $180.00 K(+3.1%) |
| Dec 2013 | $174.60 K(-23.1%) | $50.20 K(+17.3%) | $174.60 K(+0.5%) |
| Sep 2013 | - | $42.80 K(+8.4%) | $173.80 K(-5.0%) |
| Jun 2013 | - | $39.50 K(-6.2%) | $183.00 K(-9.0%) |
| Mar 2013 | - | $42.10 K(-14.8%) | $201.10 K(-11.4%) |
| Dec 2012 | $227.00 K(-25.3%) | $49.40 K(-5.0%) | $227.00 K(-12.0%) |
| Sep 2012 | - | $52.00 K(-9.7%) | $258.00 K(-9.9%) |
| Jun 2012 | - | $57.60 K(-15.3%) | $286.30 K(-4.8%) |
| Mar 2012 | - | $68.00 K(-15.4%) | $300.70 K(-1.1%) |
| Dec 2011 | $304.00 K(-19.1%) | $80.40 K(+0.1%) | $304.00 K(-2.9%) |
| Sep 2011 | - | $80.30 K(+11.5%) | $313.00 K(-4.3%) |
| Jun 2011 | - | $72.00 K(+1.0%) | $327.20 K(-6.5%) |
| Mar 2011 | - | $71.30 K(-20.2%) | $349.90 K(-6.9%) |
| Dec 2010 | $375.80 K(-11.5%) | $89.40 K(-5.4%) | $375.70 K(-3.8%) |
| Sep 2010 | - | $94.50 K(-0.2%) | $390.70 K(-4.2%) |
| Jun 2010 | - | $94.70 K(-2.5%) | $407.80 K(-2.7%) |
| Mar 2010 | - | $97.10 K(-7.0%) | $419.20 K(-1.2%) |
| Dec 2009 | $424.40 K(-17.3%) | $104.40 K(-6.5%) | $424.40 K(-1.4%) |
| Sep 2009 | - | $111.60 K(+5.2%) | $430.40 K(+49.7%) |
| Jun 2009 | - | $106.10 K(+3.7%) | $287.50 K(-30.1%) |
| Mar 2009 | - | $102.30 K(-7.3%) | $411.30 K(-19.8%) |
| Dec 2008 | $513.10 K(-48.3%) | $110.40 K(-452.7%) | $513.10 K(+27.4%) |
| Sep 2008 | - | -$31.30 K(-113.6%) | $402.70 K(-7.2%) |
| Jun 2008 | - | $229.90 K(+12.6%) | $434.00 K(+112.6%) |
| Mar 2008 | - | $204.10 K | $204.10 K |
| Dec 2007 | $992.40 K(+935.9%) | - | - |
| Dec 2006 | $95.80 K(-33.1%) | - | - |
| Dec 2005 | $143.20 K | - | - |
FAQ
- What is ReShape Lifesciences annual depreciation & amortization?
- What is the all time high annual D&A for ReShape Lifesciences?
- What is ReShape Lifesciences annual D&A year-on-year change?
- What is ReShape Lifesciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly D&A year-on-year change?
- What is ReShape Lifesciences TTM depreciation & amortization?
- What is the all time high TTM D&A for ReShape Lifesciences?
- What is ReShape Lifesciences TTM D&A year-on-year change?
What is ReShape Lifesciences annual depreciation & amortization?
The current annual D&A of RSLS is $154.00 K
What is the all time high annual D&A for ReShape Lifesciences?
ReShape Lifesciences all-time high annual depreciation & amortization is $2.15 M
What is ReShape Lifesciences annual D&A year-on-year change?
Over the past year, RSLS annual depreciation & amortization has changed by -$2.00 M (-92.85%)
What is ReShape Lifesciences quarterly depreciation & amortization?
The current quarterly D&A of RSLS is $5000.00
What is the all time high quarterly D&A for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly depreciation & amortization is $555.00 K
What is ReShape Lifesciences quarterly D&A year-on-year change?
Over the past year, RSLS quarterly depreciation & amortization has changed by -$45.00 K (-90.00%)
What is ReShape Lifesciences TTM depreciation & amortization?
The current TTM D&A of RSLS is $24.00 K
What is the all time high TTM D&A for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM depreciation & amortization is $2.20 M
What is ReShape Lifesciences TTM D&A year-on-year change?
Over the past year, RSLS TTM depreciation & amortization has changed by -$638.00 K (-96.37%)